Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
BACKGROUND: the effect of diabetes mellitus on the long-term patency of autovenous femoro-popliteal bypass has not been definitively determined AIM: to determine the effect of diabetes mellitus on the long-term outcomes of autovenous femoral-popliteal bypass.MATERIALS AND METHODS: the results of treatment of 648 patients who underwent autovenous femoral-popliteal bypass were analyzed. The patients were divided into 2 clinical groups: the first group included 367 patients with diabetes mellitus, the second — 281 patients without the named disease. The groups did not differ significantly in the incidence of concomitant pathology.RESULTS: occlusion of the autovenous conduit within a 5-year period after surgical treatment was observed in 218 patients of the first group (59.4%) and 72 patients of the second group (25.6%) (p <0.01, χ2 = 39.05, RR = 1.78; CI = 1.53–2.12). The average service life of the autovenous femoral-popliteal bypass was 63.49 months in patients of the first group, and 107.46 months in the second. The decompensated course of diabetes mellitus was observed in 203 patients (55.2%). Among patients with decompensated diabetes mellitus, occlusion of the autovenous femoral-popliteal bypass was observed in 95 patients (46.8%), in 104 patients the autovenous conduit was passable (51.2%; p = 0.449, χ2 = 0.57). Decompensated course of diabetes mellitus may contribute to a decrease in the service life of autovenous femoro-popliteal bypass.CONCLUSION: the presence of diabetes mellitus, and especially its decompensated course, can negatively affect the patency of autovenous femoro-popliteal bypass in the long term.
BACKGROUND: the effect of diabetes mellitus on the long-term patency of autovenous femoro-popliteal bypass has not been definitively determined AIM: to determine the effect of diabetes mellitus on the long-term outcomes of autovenous femoral-popliteal bypass.MATERIALS AND METHODS: the results of treatment of 648 patients who underwent autovenous femoral-popliteal bypass were analyzed. The patients were divided into 2 clinical groups: the first group included 367 patients with diabetes mellitus, the second — 281 patients without the named disease. The groups did not differ significantly in the incidence of concomitant pathology.RESULTS: occlusion of the autovenous conduit within a 5-year period after surgical treatment was observed in 218 patients of the first group (59.4%) and 72 patients of the second group (25.6%) (p <0.01, χ2 = 39.05, RR = 1.78; CI = 1.53–2.12). The average service life of the autovenous femoral-popliteal bypass was 63.49 months in patients of the first group, and 107.46 months in the second. The decompensated course of diabetes mellitus was observed in 203 patients (55.2%). Among patients with decompensated diabetes mellitus, occlusion of the autovenous femoral-popliteal bypass was observed in 95 patients (46.8%), in 104 patients the autovenous conduit was passable (51.2%; p = 0.449, χ2 = 0.57). Decompensated course of diabetes mellitus may contribute to a decrease in the service life of autovenous femoro-popliteal bypass.CONCLUSION: the presence of diabetes mellitus, and especially its decompensated course, can negatively affect the patency of autovenous femoro-popliteal bypass in the long term.
BACKGROUND: Reconstructive surgery of multilevel lesions in peripheral atherosclerosis has been undergoing changes over the past decades. The spectrum of such interventions includes conventional, endovascular and hybrid technologies. Due to the fact that the main goal of treatment is to preserve the limb, the outcome of the surgical intervention directly affects the quality of patients life; however, there is insufficient data in the literature on the tactics of postoperative rehabilitation of patients who underwent surgery for a multilevel lesion. Randomized clinical trials aimed at studying the effectiveness of walk training and rehabilitation measures demonstrate an increase in walking distance in people with peripheral atherosclerosis against the background of controlled physical exertion. АIM: To assess the effect of rehabilitation program on the vital activity levels in the patients who suffered from multilevel peripheral arterial disease in a long-term period after revascularization. MATERIALS AND METHODS: The study included 216 patients with MPAD who underwent various lower limb revascularization, including 87 patients with hybrid interventions, 81 open surgery and 48 with endovascular interventions. The patients have been examined both in perioperative and postoperative periods as well as in a long-term period (36 months) after reconstruction. Depending on the fulfillment or non-fulfillment of the proposed rehabilitation program, such indicators as limb preservation, walking distance and quality of patients life have been evaluated in accordance with the EQ-5D questionnaire. RESULTS: In the early postoperative period, a decrease in the number of thrombosis of the operated segment has been registered in the group of hybrid interventions in comparison with the results in the group with open operations. In the long-term period after the operation, the use of complex rehabilitation measures allowed to reduce the number of amputations and stabilize the maximum walking distance. Walk training provided the necessary level of quality of life, which, in most cases, has been recorded in the patients who underwent hybrid interventions. CONCLUSIONS: The composition and fullness of rehabilitation program is a circumstance affecting long-term outcomes after reconstructive vascular interventions. The exclusion of walk training from the rehabilitation program does not allow achieving the maximum frequency of limb preservation, increasing the walking distance and improving the quality of life of patients suffering from multilevel lesion of the arteries of the lower extremities.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.